[Immunotherapy in type 1 (insulin-dependent) diabetes].
D000818:Animals; D016026:Bone Marrow Transplantation; D002648:Child; D003524:Cyclosporins / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000628:therapy; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy; D007542:Inosine Pranobex / Q000627:therapeutic use; D007370:Interferon Type I / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D051381:Rats; D013934:Thymectomy
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D007370:Interferon Type I; D007978:Levamisole; D011241:Prednisone; D007542:Inosine Pranobex
L'immunoterapia nel diabete di tipo I (insulino-dipendente).